Meningioma diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
== Overview == | == Overview == | ||
MRI is the gold standard test for the diagnosis of meningioma. | |||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
Revision as of 15:21, 21 June 2019
|
Meningioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Meningioma diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Meningioma diagnostic study of choice |
|
Risk calculators and risk factors for Meningioma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
MRI is the gold standard test for the diagnosis of meningioma.
Diagnostic Study of Choice
Study of choice
MRI is the gold standard test for the diagnosis of meningioma.[1][2]
References
- ↑ Watts J, Box G, Galvin A, Brotchie P, Trost N, Sutherland T (2014). "Magnetic resonance imaging of meningiomas: a pictorial review". Insights Imaging. 5 (1): 113–22. doi:10.1007/s13244-013-0302-4. PMC 3948902. PMID 24399610.
- ↑ Nowosielski M, Galldiks N, Iglseder S, Kickingereder P, von Deimling A, Bendszus M; et al. (2017). "Diagnostic challenges in meningioma". Neuro Oncol. 19 (12): 1588–1598. doi:10.1093/neuonc/nox101. PMC 5716093. PMID 28531331.